Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis-Reference-Cited by-同舟云学术

Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis

Published:2011-02-18 Issue:2 Volume:6 Page:e17260
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Davis Joshua S.,Darcy Christabelle J.,Yeo Tsin W.,Jones Catherine,McNeil Yvette R.,Stephens Dianne P.,Celermajer David S.,Anstey Nicholas M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study.;M Juonala;Circulation,2007

2. Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.;V De Gennaro Colonna;Med Sci Monit,2009

3. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.;DC Angus;Crit Care Med,2001

4. The epidemiology of sepsis in the United States from 1979 through 2000.;GS Martin;N Engl J Med,2003

5. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome.;WC Aird;Blood,2003

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial dysfunction: Pathophysiology and therapeutic targets for sepsis-induced multiple organ dysfunction syndrome;Biomedicine & Pharmacotherapy;2024-09

2. Changes in nitric oxide inhibitors and mortality in critically ill patients: a cohort study;Annals of Intensive Care;2024-08-27

3. CAPE ameliorates vascular damage caused by sepsis;Cukurova Medical Journal;2024-03-29

4. A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach;Critical Care;2022-08-12

5. Could Asymmetric Dimethylarginine Have a Role in COVID-19 Cases?;Bagcilar Medical Bulletin;2022-06-17